+ All Categories

Home > Documents > Including Elderly Patients with NVAF and Long-Term Care...XARELTO@ is indicated to reduce the risk...

Including Elderly Patients with NVAF and Long-Term Care...XARELTO@ is indicated to reduce the risk...

Date post:	25-Feb-2021
Category:	Documents
Upload:	others
View:	1 times
Download:	0 times

Download Report this document

Share this document with a friend

Embed Size (px):

2

Including Elderly Patients with NVAF and Long-Term Care OUR GUEST SPEAKER WILL BE Sean Cannone, DO, CMD Senior Vice President Consortium Concepts, LLC Copley, OH Dr. Sean Cannone is a paid speaker for Janssen Pharmaceuticals, Inc. DATE/TIME Tuesday September 12, 2017 7:30 PM LCATION Fleming's Prime Steakhouse 4000 Medina Road Akron, OH 44333 (330) 670-5200 RSVP: Please RSVP to your Janssen Representative before Tuesday, September 05, 2017 or visit http://www.medforcereg.net/SOMP119875 Zachary Gantz (724) 866-3996

Transcript

Page 1: Including Elderly Patients with NVAF and Long-Term Care...XARELTO@ is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation

Including Elderly Patients with NVAFand Long-Term Care

OUR GUEST SPEAKER WILL BESean Cannone, DO, CMDSenior Vice PresidentConsortium Concepts, LLCCopley, OH Dr. Sean Cannone is a paid speaker for Janssen Pharmaceuticals, Inc.

DATE/TIMETuesdaySeptember 12, 2017

7:30 PM LCATIONFleming's PrimeSteakhouse4000 Medina RoadAkron, OH 44333 (330) 670-5200

RSVP:Please RSVP to yourJanssen Representative before Tuesday,September 05, 2017or visithttp://www.medforcereg.net/SOMP119875 Zachary Gantz(724) 866-3996

Page 2: Including Elderly Patients with NVAF and Long-Term Care...XARELTO@ is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation

Recommended

Patient Safety: Patients’ Perspective. A.K... · Patient Safety: Patients’ Perspective. ... Channels for constructive dialogue between patients and ... Patients/ attendants expect

Determination of Highest Risk Patients Adult Patients.

Nonvalvular Cardiovascular Device–Related Infections

STUDY PROTOCOL Open Access Study protocol: the DESPATCH ... · clot embolism to large arteries of the brain [1]. NVAF is more prevalent with increasing age, affecting 1 in 20 people

Case study - patient presenting with newly diagnosed NVAF with prior CAD Full Prescribing Information…

Title Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation Clinical Trial Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with.

Chronic Lyme Patients Patients Plead for Help

EVIDENCE BASED GUIDELINE: PREVENTION OF STROKE IN ... · 1 Evidence-based guideline update: Prevention of stroke in nonvalvular atrial fibrillation Report of the Guideline Development

Devices to Reduce Stroke Risk in Patients Who Can’t Take ... · •150 patients with nonvalvular AF and CHADS 2 ≥1, who were considered ineligible for warfarin •Primary endpoint

Early Recurrence and Major Bleeding in Patients With Acute ...eprints.gla.ac.uk/148087/7/148087.pdf · however, in this article, we report only patients who received a NOAC. Nonvalvular

Patients Rights, Patients, Hospital Patient Rights, Hospital

Patients with special needs (blind patients, deaf blind patients)

ARE YOUR PATIENTS GETTING COMFORTABLY NUMB? Patients …

Patients with special needs (mentally unstable patients, aggressive patients, anxious patients, depressive patients, socially disadvantaged patients, patients.

Santen Pharmaceutical Meeting on Long-term Vision · 1 day ago · Brand Communication Therapeutic patients Number of patients Diagnostic patients Number of patients Diagnostic patients

Sensorineural Hearing Loss: More than Meets the Eye?mations (three patients), sarcoidosis (three patients), metastasis (two patients), lymphoma (two patients), lipomas (two patients),

Anticoagulant therapy, coumadines or direct antithrombins...Antithrombotic therapy in NVAF update % Relative risk reduction of Stroke or MACE* in NVAF % RRR * P < 0.01 0 20 War v Pla

New Kids on the Block: A case based review of the NOACs · Case 1 • Note all studies of the NOACs only included nonvalvular atrial fibrillation • No studies included patients